These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Genetics and the prediction of complications in type 1 diabetes. Marre M. Diabetes Care; 1999 Mar; 22 Suppl 2():B53-8. PubMed ID: 10097900 [Abstract] [Full Text] [Related]
28. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Chowdhury TA, Dronsfield MJ, Kumar S, Gough SL, Gibson SP, Khatoon A, MacDonald F, Rowe BR, Dunger DB, Dean JD, Davies SJ, Webber J, Smith PR, Mackin P, Marshall SM, Adu D, Morris PJ, Todd JA, Barnett AH, Boulton AJ, Bain SC. Diabetologia; 1996 Sep; 39(9):1108-14. PubMed ID: 8877296 [Abstract] [Full Text] [Related]
29. Risk factors for development of diabetic nephropathy: a review. Strojek K, Grzeszczak W, Ritz E. Nephrol Dial Transplant; 1997 Sep; 12 Suppl 2():24-6. PubMed ID: 9269695 [Abstract] [Full Text] [Related]
30. [Angiotensin converting enzyme gene polymorphism and type 2 diabetic nephropathy]. Liao L, Lei MX, Chen HL. Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):553-6. PubMed ID: 15804059 [Abstract] [Full Text] [Related]
31. [Association between insertion-deletion polymorphism of the angiotensin-converting enzyme gene and development of angiopathies in patients with non-insulin dependent diabetes mellitus from the Chuvash Republic]. Miloserdova OV, Slominskiĭ PA, Mauianov IV, Markov DS, Balabolkin MI, Limborskaia SA. Genetika; 2001 Jan; 37(1):112-6. PubMed ID: 11234416 [Abstract] [Full Text] [Related]
32. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians. Movva S, Alluri RV, Komandur S, Vattam K, Eppa K, Mukkavali KK, Mubigonda S, Saharia S, Shastry JC, Hasan Q. J Diabetes Complications; 2007 Jan; 21(4):237-41. PubMed ID: 17616353 [Abstract] [Full Text] [Related]
34. Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation. Lee SH, Lee TW, Ihm CG, Kim MJ, Woo JT, Chung JH. Nephrology (Carlton); 2005 Oct; 10 Suppl():S32-6. PubMed ID: 16174285 [Abstract] [Full Text] [Related]
35. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients. Tarnow L, Kjeld T, Knudsen E, Major-Pedersen A, Parving HH. Diabetologia; 2000 Jun; 43(6):794-9. PubMed ID: 10907125 [Abstract] [Full Text] [Related]
36. Angiotensin converting enzyme (ACE) activity levels in insulin-independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy. Ustündağ B, Canatan H, Cinkilinç N, Halifeoğlu I, Bahçecioğlu IH. Cell Biochem Funct; 2000 Mar; 18(1):23-8. PubMed ID: 10686580 [Abstract] [Full Text] [Related]
37. [Relationship between serum angiotensin I-converting enzyme activity and diabetic nephropathy in patients with type II diabetes]. Liao L, Lei M, Han X, Chen H, Fan C. Hunan Yi Ke Da Xue Xue Bao; 1999 Mar; 24(3):263-6. PubMed ID: 12016801 [Abstract] [Full Text] [Related]
38. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients. Böger CA, Götz AK, Krüger B, Hösl M, Schmitz G, Riegger GA, Krämer BK. Eur J Med Res; 2005 Apr 20; 10(4):161-8. PubMed ID: 15946912 [Abstract] [Full Text] [Related]
39. Assessing genetic susceptibility to diabetic nephropathy. Tanaka N, Babazono T. Nephrology (Carlton); 2005 Oct 20; 10 Suppl():S17-21. PubMed ID: 16174281 [Abstract] [Full Text] [Related]
40. [The relationship between genetic polymorphisms and disease, illustrated by the renin-angiotensin-aldosterone system and cardiovascular disease]. Spiering W, Kroon AA, Vreugdenhil HA, Geraedts JP, Daemen MJ, de Leeuw PW. Ned Tijdschr Geneeskd; 1998 Jun 20; 142(25):1445-50. PubMed ID: 9752056 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]